Monod

Developer of biosensors to detect viral proteins, toxins, antibodies, and other molecules

placeSeattle, Washington, United States calendar_todayFounded 2021 groups27 employees language monod.bio

Registered entities

Social engagement

Social engagement: 4.5K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Matrix.

Investor typeCountShare
Venture capital450%
Other / undisclosed450%

Recent activity

5 Jun 2026
Event
Closing the Loop SF 2026
4 Jun 2026
Event
3rd BioCentury Inc. Grand Rounds U.S.
22 May 2026
Event
Closing the Loop SF 2026
Coming soon